Investor Directory

Life sciences investment firm focused on biotechnology companies developing transformative therapeutics.

Growth equity firm focused on genomics, diagnostics, and life science tools companies at the forefront of biological innovation.

Crossover healthcare investment firm investing in public and private biotech, pharmaceutical, and diagnostics companies.

Healthcare-focused investment firm managing both public and private equity strategies across biopharma and health tech.

Andreessen Horowitz's dedicated bio and health fund, investing in companies at the intersection of biology and technology.

ADQ's technology investment platform, investing in growth-stage companies across MENA and emerging markets.

SoftBank's dedicated Latin America fund deploying billions into the region's fastest-growing technology companies.

New Zealand's largest and most established venture firm, investing in high-growth technology companies for over 25 years.

Canada's most active and largest venture investor, the investment arm of the Business Development Bank of Canada.

We invest in medtech, healthtec, impact

We invest in growing early-stage and middle-market healthcare services and healthcare technology companies.

We invest in mobility, transportation, automotive

We invest in Europe, US and Latam mainly. We are an industry agnostic fund, open to hear new projects.

Formerly Morningside Ventures, a leading Chinese VC investing in technology and healthcare companies.

Focus on structured products, DeFi, RWAs, and consumer-faced dapps within web3 / web2.5.

I invest in any disruptive use of AI

We invest in fintech, SAAS, IoT and energy

We invest in emerging and early-stage wellness, therapeutic and psychedelic pharmaceutical companies around the globe.

We invest in ESG, industry 4.0, SmartCity, logistics, AI

We invest in UK-based consumer brands with £1m in annualised revenue

We invest in Tech-focused and Consumer-driven Startups leveraging our 20+ investments in these sectors generating minimum 6 exits at 2X MOIC in the next 4 years. Peaceful Progress Fund is a US $10 million seed fund in Chennai, India.

We invest in regional/national leaders with high multi-regional, national, or international potential. Peninsular Capital is a majority or lead shareholder. We partner with management to structure MBO/MBI and growth capital investments in SMEs in France.

We Invest in healthcare and technology companies from seed to PreIPO. Sweet spot is $1M+ revenues and scaling/growth stage.

We invest in climate-focused startups

We invest in all sectors with other institution lead investors. We focus on great founders with great products and high standards of corporate governance. We Prefer to invest in capital-efficient companies.

We invest in FinTech, SportTech, Mobility

We invest in high growing and scalable business

We invest in CEE-based companies with a proven product and help them go global. (fintech, IoT, SaaS, deeptech, hardware, AI, data platforms, advanced manufacturing, Advanced materials, robotics)

We invest in fast-growing consumer brands (digital + ecommerce), SaaS, crypto & web3, marketplaces, mobility, and most importantly: founders with ambition.

We invest in Internet & Impact, globally

We invest in companies active in the People & Revenue domain, preferably selling to start-ups and scale-ups

We invest in Gaming, fintech, blockchain, AI, entertainment, cibersecurity and silver economy.

We invest in Proptech, Enterprise Software, Fintech

We invest in Fintech, Manufacturing, Agriculture, Software, IoT, Logistics, Edtech

We invest in founders building the next generation of financial services (focus on FinTech, InsurTech, CyberSec, Climate FinTech)

We invest in scalable solutions (SaaS, fintech, healthtech, agtech, regtech) startups addressing the problems and populations served by Save the Children's body of work: ECD through secondary education, child & maternal health, climate adaptation, financial inclusion, advocacy, fundraising.

We are sector-agnostic but are inclined towards fintech, deeptech, D2C, consumer tech businesses

We invest in IoT, Fintech, SaaS, Tech, EdTech across stages

We invest in many sectors and across numerous regions. We have an open mandate to invest in scale up and growth stage investments globally. We do not invest in bio-technology / pharmaceutical related companies

We invest in the new generation of innovators who are emerging and thriving constantly to raise capital and are mostly overlooked and underestimated.

I invest in startups, mainly looking at sports and entertainment vertical.

We invest in 5G Enterprise & Applications, Data Privacy & Security, New Emerging Technologies

We invest in the market leaders of tomorrow.

We invest in exceptional founders across Australia, Israel and Southeast Asia

We invest in fintech & blockchain startups that are past the idea stage and have clear traction

We invest in innovative tech startups founded by visionary entrepreneurs solving global problems, to deliver superior returns for our investors. We don't have any specific focus on sectors.

We invest in secondary stock of late-state private tech companies

We invest in product-led founders at the Seed stage and beyond

We invest in climate-tech companies globally from Series A to late-stage

We invest in early stage technology companies, being sector agnostic but lean towards financial services. Seed - Series A and must be revenue generating.